Use of Placental Extract in Prevention and Modification of Measles

McKhann, Charles F.

doi:10.1001/archpedi.1933.01950160017002

Search citation statements

Order By: Relevance

Paper Sections

Select...

New and Nonofficial Remedies1

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1936

2020

Publication Types

Select...

Article7

Relationship

Self Cite0

Independent7

Authors

Journals

Cited by 13 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The age and general condition of the patient. 3. The intimacy of exposure, the stage of the disease and the virulence of the infection.…”

Section: New and Nonofficial Remediesmentioning

confidence: 99%

Council on Pharmacy and Chemistry

1938

JAMA

View full text Add to dashboard Cite

“…The age and general condition of the patient. 3. The intimacy of exposure, the stage of the disease and the virulence of the infection.…”

Section: New and Nonofficial Remediesmentioning

confidence: 99%

Council on Pharmacy and Chemistry

1938

JAMA

View full text Add to dashboard Cite

“…The use of human serum in the scientific field has been reported as early as the 19th century [ 12 ]. Before the mid-20th century, most IVIG uses revolved around the management of infectious diseases [ 13 , 14 , 15 ]. The use of immunoglobulin isolated from the human serum in non-infectious conditions was first reported in 1952 [ 16 ].…”

Section: Introductionmentioning

confidence: 99%

Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review

Alsaleem

2020

Antibodies

View full text Add to dashboard Cite

Intravenous immune globulin (IVIG) is made after processing plasma from healthy donors. It is composed mainly of pooled immunoglobulin and has clinical evidence-based applications in adult and pediatric populations. Recently, several clinical applications have been proposed for managing conditions in the neonatal population, such as hemolytic disease of the newborn, treatment, and prophylaxis for sepsis in high-risk neonates, enterovirus parvovirus and COVID-19 related neonatal infections, fetal and neonatal immune-induced thrombocytopenia, neonatal hemochromatosis, neonatal Kawasaki disease, and some types of immunodeficiency. The dosing, mechanism of action, effectiveness, side effects, and adverse reactions of IVIG have been relatively well studied in adults but are not well described in the neonatal population. This review aims to provide the most recent evidence and consensus guidelines about the use of IVIG in the fetus and neonate.

show abstract

“…4 Number of control children below 7 years of age in whom measles developed. 12 Number of children who were inoculated within the optimum period of exposure of 5 days 27 Number of children who were inoculated after the optimum period of exposure. 12 Number of children who were inoculated within the optimum period of exposure of 5 days 27 Number of children who were inoculated after the optimum period of exposure.…”

mentioning

confidence: 99%

Use of Immune Globulin in the Prophylaxis of Measles

Goldstein¹

1937

Arch Pediatr Adolesc Med

View full text Add to dashboard Cite

Use of Placental Extract in Prevention and Modification of Measles

Cited by 13 publications

References 6 publications

Council on Pharmacy and Chemistry

Council on Pharmacy and Chemistry

Intravenous Immune Globulin Uses in the Fetus and Neonate: A Review

Use of Immune Globulin in the Prophylaxis of Measles

Contact Info

Product

Resources

About